How are AMGN straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the AMGN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.94%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,158.16 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a AMGN straddle?

The breakeven for the AMGN straddle priced on this page is roughly $336.73 and $383.28 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMGN market-implied 1-standard-deviation expected move is approximately 7.72%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current AMGN implied volatility affect this straddle?

AMGN ATM IV is at 26.94% with IV rank near 45.71%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

AMGN Straddle Strategy

AMGN (Amgen Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NASDAQ.

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma.

AMGN (Amgen Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $193.39B, a trailing P/E of 24.81, a beta of 0.42 versus the broader market, a 52-week range of 269.77-391.29, average daily share volume of 2.8M, a public-listing history dating back to 1983, approximately 28K full-time employees. These structural characteristics shape how AMGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.42 indicates AMGN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. AMGN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a straddle on AMGN?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current AMGN snapshot

As of June 29, 2026, spot at $359.88, ATM IV 26.94%, IV rank 45.71%, expected move 7.72%. The straddle on AMGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 32-day expiry.

Why this straddle structure on AMGN specifically: AMGN IV at 26.94% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 7.72% (roughly $27.80 on the underlying). The 32-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMGN should anchor to the underlying notional of $359.88 per share and to the trader's directional view on AMGN stock.

AMGN straddle setup

The AMGN straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMGN near $359.88, the first option leg uses a $360.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMGN chain at a 32-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMGN shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$360.00	$12.05
Buy 1	Put	$360.00	$11.23

AMGN straddle risk and reward

Net Premium / Debit: -$2,327.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$2,158.16
Breakeven(s): $336.73, $383.28
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

AMGN straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on AMGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$33,671.50
$79.58	-77.9%	+$25,714.46
$159.15	-55.8%	+$17,757.43
$238.72	-33.7%	+$9,800.39
$318.29	-11.6%	+$1,843.36
$397.86	+10.6%	+$1,458.68
$477.43	+32.7%	+$9,415.71
$557.00	+54.8%	+$17,372.75
$636.57	+76.9%	+$25,329.78
$716.14	+99.0%	+$33,286.82

When traders use straddle on AMGN

Straddles on AMGN are pure-volatility plays that profit from large moves in either direction; traders typically buy AMGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

AMGN thesis for this straddle

The market-implied 1-standard-deviation range for AMGN extends from approximately $332.08 on the downside to $387.68 on the upside. A AMGN long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current AMGN IV rank near 45.71% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on AMGN should anchor more to the directional view and the expected-move geometry. As a Healthcare name, AMGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMGN-specific events.

AMGN straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMGN alongside the broader basket even when AMGN-specific fundamentals are unchanged. Always rebuild the position from current AMGN chain quotes before placing a trade.

Frequently asked questions

What is a straddle on AMGN?: A straddle on AMGN is the straddle strategy applied to AMGN (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With AMGN stock trading near $359.88, the strikes shown on this page are snapped to the nearest listed AMGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AMGN straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the AMGN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.94%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,158.16 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AMGN straddle?: The breakeven for the AMGN straddle priced on this page is roughly $336.73 and $383.28 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMGN market-implied 1-standard-deviation expected move is approximately 7.72%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on AMGN?: Straddles on AMGN are pure-volatility plays that profit from large moves in either direction; traders typically buy AMGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current AMGN implied volatility affect this straddle?: AMGN ATM IV is at 26.94% with IV rank near 45.71%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.